✦ LIBER ✦

Gene therapy study of cytokine-transfected xenogeneic cells (Vero-interleukin-2) in patients with metastatic solid tumors

✍ Scribed by Rochlitz, Christoph; Jantscheff, Peter; Bongartz, Georg; Dietrich, Pierre-Yves; Quiquerez, Anne Lise; Schatz, Christian; Mehtali, Majid; Courtney, Michael; Tartour, Eric; Dorval, Thierry

Book ID: 110017615
Publisher: Nature Publishing Group
Year: 1999
Tongue: English
Weight: 320 KB
Volume: 6
Category: Article
ISSN: 0929-1903
DOI: 10.1038/sj.cgt.7700047

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gene therapy with cytokine-transfected x

Gene therapy with cytokine-transfected xenogenic cells (Vero-IL-2) in patients with metastatic solid tumors: mechanism(s) of elimination of the transgene-carrying cells

✍ Peter Jantscheff; Richard Herrmann; Giulio Spagnoli; Jürgen Reuter; Majid Mehtal 📂 Article 📅 1999 🏛 Springer-Verlag 🌐 English ⚖ 215 KB

Phase I clinical study applying autologo

Phase I clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer, colorectal cancer and lymphoma

✍ Schmidt-Wolf, I G H; Finke, S; Trojaneck, B; Denkena, A; Lefterova, P; Schwella, 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 95 KB

A phase-I clinical study of autologous t

A phase-I clinical study of autologous tumor cells plus interleukin-2-gene-transfected allogeneic fibroblasts as a vaccine in patients with cancer

✍ Hendrik Veelken; Andreas Mackensen; Michael Lahn; Gabriele Köhler; Daniel Becker 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 257 KB 👁 2 views

Tumor cells transfected to express immunostimulatory cytokines, or admixed with similarly modified bystander cells, are able to induce immune responses against unmodified tumor cells in animal models. For treatment of human patients, a vaccine composed of autologous tumor cells and IL-2-secreting al

Tolerance and effectiveness of recombina

Tolerance and effectiveness of recombinant interleukin-2 (r-met Hu IL-2[ala-125]) and lymphokine-activated killer cells in patients with metastatic solid tumors

✍ Stahel, R.A.; Sculier, J.P.; Jost, L.M.; Delforge, A.; Bron, D.; Gmür, J.; Oelz, 📂 Article 📅 1989 🏛 Elsevier Science ⚖ 725 KB

Phase I Trial of a B7-1 (CD80) Gene Modi

Phase I Trial of a B7-1 (CD80) Gene Modified Autologous Tumor Cell Vaccine in Combination With Systemic Interleukin-2 in Patients With Metastatic Renal Cell Carcinoma

✍ ANTONIA, SCOTT J.; SEIGNE, JOHN; DIAZ, JOSE; MURO-CACHO, CARLOS; EXTERMANN, MART 📂 Article 📅 2002 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 635 KB